259796-12-8

Basic information

• Product Name: 3,5-dichloro-N-Methoxy-N-MethylbenzaMide
• Synonyms: 3,5-dichloro-N-Methoxy-N-MethylbenzaMide
• CAS NO: 259796-12-8
• Molecular Formula: C₉H₉Cl₂NO₂
• Molecular Weight: 234.07926
• Mol File: 259796-12-8.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3,5-dichloro-N-Methoxy-N-MethylbenzaMide(CAS DataBase Reference)
• NIST Chemistry Reference: 3,5-dichloro-N-Methoxy-N-MethylbenzaMide(259796-12-8)
• EPA Substance Registry System: 3,5-dichloro-N-Methoxy-N-MethylbenzaMide(259796-12-8)

Safety Data

• Hazardous Substances Data: 259796-12-8(Hazardous Substances Data)

Usage

General Description

3,5-dichloro-N-methoxy-N-methylbenzamide is a chemical compound with the molecular formula C9H10Cl2NO2. It is a white solid crystalline substance that is soluble in organic solvents. 3,5-dichloro-N-Methoxy-N-MethylbenzaMide is commonly used in organic synthesis and pharmaceutical research as a building block for the development of various drugs and biologically active compounds. It has also been studied for its potential applications in the treatment of certain diseases and conditions. Additionally, it is known for its mild analgesic and anti-inflammatory properties, making it a candidate for further pharmaceutical development. Overall, 3,5-dichloro-N-methoxy-N-methylbenzamide is a valuable chemical with potential applications in medicinal and research fields.

Upstream product

• 1117-97-1 N,0-dimethylhydroxylamine 
• 2905-62-6 3,5-dichlorobenzoyl chloride 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 
• 51-36-5 3,5-dichlorobenzoic acid 

Downstream Products

• 14401-72-0 3',5'-dichloroacetophenone 
• 920032-86-6 (5-bromopyridin-2-yl)-(3,5-dichlorophenyl)methanone 
• 92821-92-6 1-(3,5-dichlorophenyl)propan-1-one 
• 10203-08-4 3,5-dichlorobenzaldehyde 
• 73075-58-8 5,7-dichloro isoquinoline 
• 89315-56-0 5,7-dichloro-1,2,3,4-tetrahydroisoquinoline 
• 844879-42-1 (3-bromophenyl)-(3,5-dichlorophenyl)methanone 

Relevant articles and documents

Preparation method of 5, 7-dichloro-1, 2, 3, 4-tetrahydroisoquinoline

The invention provides a preparation method of 5, 7-dichloro-1, 2, 3, 4-tetrahydroisoquinoline. The preparation method comprises the following steps: preparing a compound A by taking 3, 5-dichlorobenzoic acid as a raw material; preparing a compound B from the compound A; preparing a compound C from the compound B; preparing a compound D from the compound C; and obtaining a white solid 5, 7-dichloro-1, 2, 3, 4-tetrahydroisoquinoline from the compound D. The preparation method of 5, 7-dichloro-1, 2, 3, 4-tetrahydroisoquinoline provided by the invention has the advantages of high product purity and high product yield.

Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors

A small library of 36 functionalized benzophenone thiosemicarbazone analogs has been prepared by chemical synthesis and evaluated for their ability to inhibit the cysteine proteases cathepsin L and cathepsin B. Inhibitors of cathepsins L and B have the potential to limit or arrest cancer metastasis. The six most active inhibitors of cathepsin L (IC50 50 > 10,000 nM). The most active analog in the series, 3-bromophenyl-2′-fluorophenyl thiosemicarbazone 1, also efficiently inhibits cell invasion of the DU-145 human prostate cancer cell line.

SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE

The present invention relates to substituted pyrazoles, compositions containing such compounds and methods of treatment. The compounds are glucagon receptor antagonists and thus are useful for treating, preventing or delaying the onset of type 2 diabetes